The US biomaterials in the healthcare market are projected to grow from $65.6 Bn in 2022 to $153.4 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-30. Chronic diseases such as cardiovascular disease, cancer, and diabetes are on the rise in the US. The market is highly competitive, with several key players, including BASF SE, DSM NV, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, and Royal DSM. These companies invest heavily in research and development to develop new biomaterials and improve the performance of existing ones.
According to projections, the US biomaterials market for healthcare would increase from $65.6 Bn in 2022 to $153.4 Bn in 2030, growing at a CAGR of 11.2% during the forecast period of 2022-30.
The term "biomaterials" in the US healthcare industry refers to the use of biocompatible materials in implants and medical devices that may be utilised to replace or improve sick or damaged tissues or organs. Moreover, medications or other therapeutic agents may be delivered to particular bodily parts via biomaterials. The prevalence of chronic illnesses is rising, the population is ageing, and biomaterials technological breakthroughs are all driving forces in the industry.
Based on type, application, and end-user, the US biomaterials market in the healthcare industry may be divided. Metals, ceramics, polymers, and composites are examples of different kinds of biomaterials.
Few of the medical fields where biomaterials are used:
Hospitals, clinics, and research facilities are some of the final customers of biomaterials in the healthcare industry.
There are a number of significant competitors in the industry, including BASF SE, DSM NV, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, and Royal DSM. The market is very competitive. These businesses make significant investments in R&D to create novel biomaterials and enhance the functionality of ones that already exist.
By guaranteeing the safety and effectiveness of biomaterials used in medical devices and implants, regulatory organisations like the Food and Drug Administration (FDA) play a vital role in the biomaterials market for the healthcare industry. To assure the safety and efficacy of biomaterials used in medical devices, the FDA has devised a strict approval procedure that calls for intensive research and clinical studies. As a result, the regulatory environment may provide a substantial barrier to entry for new competitors in the biomaterials market for healthcare.
Many important variables, such as the following, are what drive the US biomaterials in the healthcare market:
There are many key players in the US biomaterials in the healthcare market, including:
To assure patient safety and product efficacy, the US healthcare regulations and regulatory environment for biomaterials in healthcare are complicated and heavily regulated. The following are some of the main guidelines and laws regulating the use of biomaterials in healthcare:
The regulatory framework for biomaterials in healthcare in the US and US healthcare regulations as a whole is created to guarantee patient safety and product efficacy. It may be time-consuming and expensive for manufacturers of medical devices and biomaterials to bring their goods to market because of the stringent rules and regulations that must be followed, but it ultimately helps patients and the healthcare sector as a whole.
1. Report Description of the US Biomaterials in the Healthcare Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. US Biomaterials in Healthcare Market Executive Summary
2.1 US Biomaterials in Healthcare Market – Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of US Biomaterials in the Healthcare Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. US Biomaterials in Healthcare Market Segmentation
4.1 By Type
4.1.1 Metallic Biomaterials
220.127.116.11 Stainless Steel
18.104.22.168 Titanium & Titanium Alloys
22.214.171.124 Cobalt-Chrome Alloys
4.1.2 Polymeric Biomaterials
126.96.36.199 Silicone Rubber
188.8.131.52 Other Polymeric Biomaterials
184.108.40.206 Calcium Phosphate
220.127.116.11 Aluminum Oxide
18.104.22.168 Calcium Sulfate
4.1.4 Natural Biomaterials
22.214.171.124 Hyaluronic Acid
4.2 By Application
126.96.36.199 Implantable Cardiac Defibrillators
188.8.131.52 Heart Valves
184.108.40.206 Vascular Grafts
220.127.116.11.1 Joint Replacement
18.104.22.168.2 Knee Replacement
22.214.171.124.3 Hip Replacement
126.96.36.199.4 Shoulder Replacement
188.8.131.52 Bioresorbable Tissue Fixation
184.108.40.206.1 Suture Anchors
220.127.116.11.2 Interference Screws
18.104.22.168.3 Meniscal Repair Tacks
22.214.171.124.1 Spinal Fusion Surgeries
126.96.36.199.2 Minimally Invasive Fusion Surgeries
188.8.131.52.3 Motion Preservation & Dynamic Stabilization Surgeries
184.108.40.206.3.1 Pedicle-Based Rod Systems
220.127.116.11.3.2 Interspinous Spacers
18.104.22.168.3.3 Artificial Discs
22.214.171.124.4 Fracture Fixation Devices
126.96.36.199.4.1 Bone Plates
188.8.131.52.5 Synthetics Bone Grafts
184.108.40.206 Contact Lenses
220.127.116.11 Intraocular Lenses
18.104.22.168 Functional Replacement of Ocular Tissues
22.214.171.124 Synthetic Corneas
126.96.36.199 Dental Implants
188.8.131.52 Dental Bone Grafts & Substitutes
184.108.40.206 Dental Membranes
220.127.116.11 Tissue Regeneration
4.2.5 Plastic Surgery
18.104.22.168 Soft-Tissue Fillers
22.214.171.124 Craniofacial Surgery
4.2.6 Wound Healing
126.96.36.199 Wound Closure Devices
188.8.131.52 Surgical Hemostats
184.108.40.206 Internal Tissue Sealants
220.127.116.11 Adhesion Barriers
18.104.22.168 Hernia Meshes
4.2.7 Tissue Engineering
22.214.171.124 Scaffolds for Regenerative Medicine
126.96.36.199 Nanomaterials for Biosensing
188.8.131.52 Tailoring of Inorganic Nanoparticles
4.2.8 Neurological/Central Nervous System Applications
184.108.40.206 Shunting Systems
220.127.116.11 Cortical Neural Prosthetics
18.104.22.168 Hydrogel Scaffolds for CNS Repair
22.214.171.124 Neural Stem Cell Encapsulation
4.2.9 Other Applications
126.96.36.199 Drug Delivery Systems
188.8.131.52 Gastrointestinal Applications
184.108.40.206 Bariatric Surgery
220.127.116.11 Urinary Applications
5. US Biomaterials in Healthcare Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in the US
8.2 Regulatory Framework in the US
8.3 Pricing & Reimbursement Scenario in US Biomaterials in Healthcare Market
9. Factors Driving Future Growth
9.1 New Trends and Development US Biomaterials in Healthcare Market
9.2 Future Opportunities
10. Strategic Recommendations
By Type (Revenue, USD Billion):
Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the US market in 2019. The growing geriatric population USly is expected to drive growth for this segment.
By Application (Revenue, USD Billion):
The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses